Citigroup’s Nuvalent NUVL Stock Holding History

Citigroup’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,400	Closed	-$1.79M	–	6239
2025 Q2	$1.79M	Buy	+23,400	New	+$1.71M	﹤0.01%	2744

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Citigroup's NUVL Position: Q2 2026 in Review

Citigroup increased its Nuvalent (NUVL) stake by 111% in Q2 2026, buying an estimated $4.37M and bringing the position to 77,348 shares worth $9.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1656.

Citigroup first reported a position in NUVL in Q3 2021 and has held it in 20 quarters since. The position peaked at $16.8M in Q1 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Citigroup held 77,348 shares of Nuvalent worth $9.55M as of Q2 2026.
Citigroup bought 40,660 Nuvalent shares in Q2 2026, an estimated $4.37M.
Nuvalent made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1656 holding.
Citigroup first reported a position in Nuvalent in Q3 2021 and has held it in 20 quarters since.
Citigroup's Nuvalent position peaked at $16.8M in Q1 2025.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.